Review: could Bone cancer metastatic cause Spinal osteoarthritis?
This is a review of Spinal osteoarthritis among 87 people who have Bone cancer metastatic. We analyze the Bone cancer metastatic patients by their gender and age, drugs used, and common conditions other than Bone cancer metastatic. The review is created by eHealthMe based on reports from FDA and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. We use data reported since 1977 till to date. All studies are personalized to gender and age. Start now >>>
Spinal osteoarthritis (joint cartilage loss in spine) (latest reports from 112,476 patients) has been reported by people with osteoporosis, osteopenia, multiple myeloma, high blood pressure, pain.
On Feb, 26, 2014: 87 people who have bone cancer metastatic are studied. Among them, 14 (16.09%) have Spinal Osteoarthritis.
Gender of people who have bone cancer metastatic and experienced Spinal osteoarthritis * :
|Spinal osteoarthritis||100.00%||0.00% |
Age of people who have bone cancer metastatic and experienced Spinal osteoarthritis * :
|Spinal osteoarthritis||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||100.00%||0.00% |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Breast cancer (14 people, 100.00%)
- Metastases to bone (14 people, 100.00%)
- Osteomyelitis (4 people, 28.57%)
Most common drugs used by these people * :
- Aredia (14 people, 100.00%)
- Selenium (14 people, 100.00%)
- Vitamin e (14 people, 100.00%)
- Nasonex (14 people, 100.00%)
- Zometa (14 people, 100.00%)
- Celebrex (14 people, 100.00%)
- Femara (14 people, 100.00%)
- Synthroid (14 people, 100.00%)
- Wellbutrin (13 people, 92.86%)
- Lexapro (13 people, 92.86%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Bone cancer metastatic, Spinal osteoarthritis
You can also:
Common treatments for Bone Cancer Metastatic and their efficacy:
Could your drug cause it?
Browse all Bone cancer metastatic symptoms from A to Z:
Comments from related studies:
From this study (1 year ago):
K S Prakash on Apr, 6, 2011:
I used Lopid 300 mg once a day for about 3 to 3.5 months. My blood sugar levels rose...
I stopped Lopid.
Lopid also caused pain in the lower ribs, just above the stomach apart from muscle weakness.
I stopped the drug and awaiting for improvement.
Fresno on Dec, 9, 2012:
Over the past year, I have lost substantial muscle tone. Strength remains ok but significant change is hardness of muscles though my diet and workout routine remain the same. I stopped finasteride and continue to loss muscle tone. Have had blood work and other tests all negative. Any suggestions
william mcniff on Nov, 20, 2012:
No one lost muscle tissue/weight during or after the BMT????Really??? I lost 75lbs during and after my BMT. 205 to 130lbs. I have no muscle mass at all.
It has been over 4 years since my transplant and I still cannot rebuild the lost muscle. This is with
testosterone shots weight training BCAA Whey protein
creatine etc etc etc.
I find it hard to believe muscle wasting did not occur with other patients.
From this study (2 years ago):
diagnosed with mBC in the bones. Fairly advanced, working to manage pain.
nl_adams on Jul, 3, 2012:
Does xeloda aggravate shingles and if so for how long?
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Bone cancer metastatic, Spinal osteoarthritis
More reviews for: Bone cancer metastatic, Spinal osteoarthritis
Related drug studies for: Bone cancer metastatic, Spinal osteoarthritis
Recent Bone Cancer Metastatic related drug comparison:
More related comparison studies for: Bone cancer metastatic, Spinal osteoarthritis
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.